Search - tctmd.com

Displaying 81 - 100 of 135

Sort: Relevancy | Date

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Biotronik wins CE Mark for new MRI-safe pacemakers

July 30, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Industry News

HeartWare launches European trial for next-gen MVAD heart pump

July 20, 2015

News Industry News

Thoratec Receives CE Mark Approval For HeartMate PHP™

July 13, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

L.A. McKeown

June 22, 2015

News Industry News

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

June 22, 2015

News Industry News

Medtronic Acquires Aptus Endosystems

June 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

May 15, 2015

News Daily News

Carotid Stenting, Endarterectomy Equally Effective at Preventing Severe Strokes in Symptomatic Patients

L.A. McKeown

October 24, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

Presentation TCT 2014

PCI Outcomes in Diabetic Patients Outside the United States and European Union

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Alfredo E. Rodriguez

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

New clinical trial results for Miracor’s PICSO® Impulse System in Acute Myocardial Infarction will be reported at ‘TCT 2014’

September 09, 2014

News Industry News

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

July 17, 2014

Advertisement

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Biotronik wins CE Mark for new MRI-safe pacemakers

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

HeartWare launches European trial for next-gen MVAD heart pump

Thoratec Receives CE Mark Approval For HeartMate PHP™

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

Medtronic Acquires Aptus Endosystems

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

Carotid Stenting, Endarterectomy Equally Effective at Preventing Severe Strokes in Symptomatic Patients

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

PCI Outcomes in Diabetic Patients Outside the United States and European Union

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

New clinical trial results for Miracor’s PICSO® Impulse System in Acute Myocardial Infarction will be reported at ‘TCT 2014’

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content